Permanently Discontinued

APO-BRIMONIDINE

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is APO-BRIMONIDINE discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that APO-BRIMONIDINE 0.2% has been permanently discontinued (last updated November 16, 2020). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is APO-BRIMONIDINE not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products

Affected strength0.2%

Last updated2020-11-16

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

ALPHAGAN

ABBVIE CORPORATION

0.2% · DIN 02236876

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION 0.2%

ALCON CANADA INC

0.2% · DIN 02245942

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

RATIO-BRIMONIDINE

TEVA CANADA LIMITED

0.2% · DIN 02243026

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

PMS-BRIMONIDINE

PHARMASCIENCE INC

0.2% · DIN 02246284

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

BRIMONIDINE OPHTHALMIC

PHARMEL INC

0.2% · DIN 02246283

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

BRIMONIDINE

PHARMASCIENCE INC

0.2% · DIN 02249456

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

APO-BRIMONIDINE-TIMOP

APO-BRIMONIDINE-TIMOP: The weight is out of specification in the affected lot.

Type II2026-03-05

Moderate health risk

Possible match — not confirmed

DIN

02260077

Strength

0.2%

Dosage Form

SOLUTION

Route

OPHTHALMIC

Active Ingredient

BRIMONIDINE TARTRATE

See all BRIMONIDINE TARTRATE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

Permanently Discontinued

Business reasons

Permanently Discontinued

Business reasons

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244

10MG · DIN 02240414

20MG · DIN 02296098

150MG · DIN 02296160

75MG · DIN 02230507

2MG · DIN 02554194

2MG · DIN 02554178